Aptevo Therapeutics Inc. (APVO) ownership: Top institutional holder: BlackRock Fund Advisors ($1.19M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock Fund Advisors | 485457.00 | $1.19M | 2016-12-31 |
| Point72 Asset Management, L.P. | 299944.00 | $434919.00 | 2025-09-30 |
| VANGUARD GROUP INC | 16856.00 | $158952.00 | 2025-12-31 |
| GSA CAPITAL PARTNERS LLP | 19638.00 | $84000.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 13337.00 | $56948.00 | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 12713.00 | $54285.00 | 2026-03-31 |
| CITIGROUP INC | 2756.00 | $25989.00 | 2025-12-31 |
| CITADEL ADVISORS LLC | 111632.00 | $20071.00 | 2024-09-30 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-06 | |
| Sell | null | 2026-08-06 | |
| Sell | null | 2026-08-06 | |
| Sell | null | 2026-08-06 | |
| Sell | null | 2026-08-06 | |
| Sell | null | 2026-08-06 | |
| Sell | null | 2026-08-06 | |
| Sell | null | 2026-08-06 |
Back to APVO overview · APVO earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.